产品: | 磷酸化 CtIP (Ser327) 抗体 |
货号: | AF8004 |
描述: | Rabbit polyclonal antibody to Phospho-CtIP (Ser327) |
应用: | WB IHC |
反应: | Human, Mouse, Rat |
预测: | Pig, Bovine, Horse, Sheep, Rabbit, Dog |
分子量: | 102kDa; 102kD(Calculated). |
蛋白号: | Q99708 |
RRID: | AB_2840067 |
产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# AF8004, RRID:AB_2840067.
展开/折叠
COM1; COM1_HUMAN; CtBP interacting protein; CtBP-interacting protein; CtIP; DNA endonuclease RBBP8; JWDS; RBBP-8; RBBP8; Retinoblastoma-binding protein 8; Retinoblastoma-interacting protein and myosin-like; Rim; SAE2; SCKL2; Sporulation in the absence of SPO11 protein 2 homolog;
抗原和靶标
Expressed in ER-positive breast cancer lines, but tends to be down-regulated ER-negative cells (at protein level).
- Q99708 CTIP_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MNISGSSCGSPNSADTSSDFKDLWTKLKECHDREVQGLQVKVTKLKQERILDAQRLEEFFTKNQQLREQQKVLHETIKVLEDRLRAGLCDRCAVTEEHMRKKQQEFENIRQQNLKLITELMNERNTLQEENKKLSEQLQQKIENDQQHQAAELECEEDVIPDSPITAFSFSGVNRLRRKENPHVRYIEQTHTKLEHSVCANEMRKVSKSSTHPQHNPNENEILVADTYDQSQSPMAKAHGTSSYTPDKSSFNLATVVAETLGLGVQEESETQGPMSPLGDELYHCLEGNHKKQPFEESTRNTEDSLRFSDSTSKTPPQEELPTRVSSPVFGATSSIKSGLDLNTSLSPSLLQPGKKKHLKTLPFSNTCISRLEKTRSKSEDSALFTHHSLGSEVNKIIIQSSNKQILINKNISESLGEQNRTEYGKDSNTDKHLEPLKSLGGRTSKRKKTEEESEHEVSCPQASFDKENAFPFPMDNQFSMNGDCVMDKPLDLSDRFSAIQRQEKSQGSETSKNKFRQVTLYEALKTIPKGFSSSRKASDGNCTLPKDSPGEPCSQECIILQPLNKCSPDNKPSLQIKEENAVFKIPLRPRESLETENVLDDIKSAGSHEPIKIQTRSDHGGCELASVLQLNPCRTGKIKSLQNNQDVSFENIQWSIDPGADLSQYKMDVTVIDTKDGSQSKLGGETVDMDCTLVSETVLLKMKKQEQKGEKSSNEERKMNDSLEDMFDRTTHEEYESCLADSFSQAADEEEELSTATKKLHTHGDKQDKVKQKAFVEPYFKGDERETSLQNFPHIEVVRKKEERRKLLGHTCKECEIYYADMPAEEREKKLASCSRHRFRYIPPNTPENFWEVGFPSTQTCMERGYIKEDLDPCPRPKRRQPYNAIFSPKGKEQKT
种属预测
score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。
High(score>80) Medium(80>score>50) Low(score<50) No confidence
翻译修饰 - Q99708 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
S4 | Phosphorylation | Uniprot | |
S10 | Phosphorylation | Uniprot | |
S17 | Phosphorylation | Uniprot | |
S18 | Phosphorylation | Uniprot | |
K62 | Ubiquitination | Uniprot | |
K115 | Sumoylation | Uniprot | |
S163 | Phosphorylation | Uniprot | |
S231 | Phosphorylation | Uniprot | |
S233 | Phosphorylation | Uniprot | |
T245 | Phosphorylation | Uniprot | |
S276 | Phosphorylation | Uniprot | |
S309 | Phosphorylation | Uniprot | |
K314 | Ubiquitination | Uniprot | |
T315 | Phosphorylation | P24941 (CDK2) | Uniprot |
T323 | Phosphorylation | Uniprot | |
S326 | Phosphorylation | Uniprot | |
S327 | Phosphorylation | Uniprot | |
S345 | Phosphorylation | Uniprot | |
S347 | Phosphorylation | Uniprot | |
S349 | Phosphorylation | Uniprot | |
K360 | Ubiquitination | Uniprot | |
T361 | Phosphorylation | Uniprot | |
K378 | Sumoylation | Uniprot | |
K378 | Ubiquitination | Uniprot | |
S379 | Phosphorylation | Uniprot | |
K410 | Ubiquitination | Uniprot | |
T422 | Phosphorylation | Uniprot | |
Y424 | Phosphorylation | Uniprot | |
S428 | Phosphorylation | Uniprot | |
K432 | Acetylation | Uniprot | |
K438 | Sumoylation | Uniprot | |
K438 | Ubiquitination | Uniprot | |
S439 | Phosphorylation | Uniprot | |
K449 | Sumoylation | Uniprot | |
T450 | Phosphorylation | Uniprot | |
K513 | Acetylation | Uniprot | |
K515 | Acetylation | Uniprot | |
Y522 | Phosphorylation | Uniprot | |
K526 | Acetylation | Uniprot | |
K526 | Ubiquitination | Uniprot | |
K530 | Ubiquitination | Uniprot | |
S539 | Phosphorylation | Uniprot | |
S549 | Phosphorylation | Uniprot | |
S555 | Phosphorylation | Uniprot | |
S568 | Phosphorylation | Uniprot | |
K578 | Sumoylation | Uniprot | |
K585 | Ubiquitination | Uniprot | |
S593 | Phosphorylation | Uniprot | |
K604 | Acetylation | Uniprot | |
K604 | Sumoylation | Uniprot | |
K604 | Ubiquitination | Uniprot | |
K613 | Ubiquitination | Uniprot | |
K640 | Ubiquitination | Uniprot | |
S649 | Phosphorylation | Uniprot | |
S664 | Phosphorylation | Q13315 (ATM) | Uniprot |
S679 | Phosphorylation | Uniprot | |
S723 | Phosphorylation | Uniprot | |
S745 | Phosphorylation | Q13315 (ATM) | Uniprot |
K760 | Ubiquitination | Uniprot | |
K774 | Sumoylation | Uniprot | |
K782 | Ubiquitination | Uniprot | |
S836 | Phosphorylation | Uniprot | |
T847 | Phosphorylation | P24941 (CDK2) | Uniprot |
T859 | Phosphorylation | Q13535 (ATR) | Uniprot |
K869 | Sumoylation | Uniprot | |
S889 | Phosphorylation | Uniprot |
研究背景
Endonuclease that cooperates with the MRE11-RAD50-NBN (MRN) complex in DNA-end resection, the first step of double-strand break (DSB) repair through the homologous recombination (HR) pathway. HR is restricted to S and G2 phases of the cell cycle and preferentially repairs DSBs resulting from replication fork collapse. Key determinant of DSB repair pathway choice, as it commits cells to HR by preventing classical non-homologous end-joining (NHEJ). Functions downstream of the MRN complex and ATM, promotes ATR activation and its recruitment to DSBs in the S/G2 phase facilitating the generation of ssDNA. Component of the BRCA1-RBBP8 complex that regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage. During immunoglobulin heavy chain class-switch recombination, promotes microhomology-mediated alternative end joining (A-NHEJ) and plays an essential role in chromosomal translocations (By similarity).
Acetylated. Deacetylation by SIRT6 upon DNA damage promotes DNA end resection.
Hyperphosphorylation upon ionizing radiation results in dissociation from BRCA1. Phosphorylation at Thr-847 by CDK1 is essential for the recruitment to DNA and the DNA repair function. Phosphorylated on Ser-327 as cells enter G2 phase. This phosphorylation is required for binding BRCA1 and for the G2/M DNA damage transition checkpoint control. Phosphorylation at Thr-315, probably catalyzed by CDK2, is required for PIN1-binding, while phosphorylation at Ser-276 serves as a PIN1 isomerization site. Phosphorylation at Thr-315 is cell-cycle dependent. It steadily increases during S phase, peaks at late S/G2 phase, and drops at G1.
Ubiquitinated. Ubiquitination at multiple sites by BRCA1 (via its N-terminal RING domain) does not lead to its proteasomal degradation but instead the ubiquitinated RBBP8 binds to chromatin following DNA damage and may play a role in G2/M checkpoint control. Ubiquitinated by RNF138 at its N-terminus. Ubiquitinated through 'Lys-48' by the E3 CUL3-KLHL15 complex; this modification leads to proteasomal degradation. Ubiquitinated by the E3 FZR1/APC/C complex; this modification leads to proteasomal degradation.
Nucleus. Chromosome.
Note: Associates with sites of DNA damage in S/G2 phase (PubMed:10764811, PubMed:25349192). Ubiquitinated RBBP8 binds to chromatin following DNA damage (PubMed:16818604).
Expressed in ER-positive breast cancer lines, but tends to be down-regulated ER-negative cells (at protein level).
Homodimer; dimerizes via the coiled coil domain. Interacts (via the PXDLS motif) with CTBP1; the interaction is disrupted via binding of the adenovirus E1A to CTBP1. Component of the BRCA1-RBBP8 complex. Interacts (the Ser-327 phosphorylated form) with BRCA1 (via the C-terminal BRCA1 domains): the interaction occurs in the G2 phase, ubiquitinates RBBP8 and involves RBBP8 in BRCA1-dependent G2/M checkpoint control on DNA damage. Interacts with RB1. Interacts with the MRN complex. Interacts directly with MRE11; the interaction is required for efficient homologous recombination (HR) and regulation of the MRN complex. Interacts directly with RAD50. Interacts directly with NBN. Interacts with SIRT6; the interaction deacetylates RBBP8 upon DNA damage. Interacts with LM04 (via the LIM zinc-binding 1 domain). Interacts with SIAH1. Interacts with RNF138. Interacts with EXD2. Interacts with CUL3 and KLHL15; this interaction leads to RBBP8 proteasomal degradation. Directly interacts with PIN1; this interaction depends upon RBBP8 phosphorylation, predominantly at Thr-315. Interacts with FZR1; this interaction leads to APC/C-mediated RBBP8 proteasomal degradation. Interacts with AUNIP; leading to recruit RBBP8 to sites of DNA damage. Interacts with SAMHD1.
The PXDLS motif binds to a cleft in CtBP proteins.
The damage-recruitment motif is required for DNA binding and translocation to sites of DNA damage.
Belongs to the COM1/SAE2/CtIP family.
研究领域
· Genetic Information Processing > Replication and repair > Homologous recombination.
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.